Author(s): Sathyavathy. G

Email(s): gsathyavathybablu@gmail.com

DOI: 10.52711/ijnmr.2023.14   

Address: Mrs. Sathyavathy. G
Associate Professor, Sri Manakula Vinayagar Nursing College, Puducherry.
*Corresponding Author

Published In:   Volume - 2,      Issue - 2,     Year - 2023


ABSTRACT:
Crimean-Congo haemorrhagic fever (CCHF) is a viral infection that can kill a lot of people and is found in about 30 countries. It is the most widespread of the medically important diseases caused by ticks and is very close to how Hyalomma spp. ticks are found all over the world. Tick bites, crushing infected ticks, contact with a patient with CCHF during the acute phase of the infection, or contact with blood or tissues from viraemic livestock are all ways in which humans contract the disease. Clinical highlights regularly show an emotional movement described by drain, myalgia, and fever. Lactate dehydrogenase, creatinine phosphokinase, and liver enzymes all rise, and bleeding markers last longer. The endothelium infection is a major pathogen. In finding, protein connected immunoassay and continuous opposite transcriptase PCR are utilized. Early finding is basic for patient treatment and the counteraction of expected nosocomial diseases. The most essential component of case management is supportive therapy. When treating patients who have hemorrhages from the nose, mouth, gums, vagina, and injection sites, healthcare workers run a high risk of infection. Straightforward boundary safety measures have been accounted for to be compelling.


Cite this article:
Sathyavathy. G. Crimean-Congo Hemorrhagic Fever (CCHF). A and V Pub International Journal of Nursing and Medical Research. 2023; 2(2):52-5. doi: 10.52711/ijnmr.2023.14

Cite(Electronic):
Sathyavathy. G. Crimean-Congo Hemorrhagic Fever (CCHF). A and V Pub International Journal of Nursing and Medical Research. 2023; 2(2):52-5. doi: 10.52711/ijnmr.2023.14   Available on: https://ijnmronline.com/AbstractView.aspx?PID=2023-2-2-8


REFERENCE:
I.    JOURNAL REFERENCE

1.    Al-Abri SS, Abaidani IA et.al, Current status of Crimean-Congo hemorrhagic fever in the World Health Organization eastern Mediterranean region: issues, challenges, and future directions. Int J Infect Dis. 2017;58:82-9.
2.    Bażanów BA, Pacoń J, Gadzała Ł, Frącka A, Welz M, Paweska J. Vector and serologic survey for Crimean-Congo hemorrhagic fever virus in Poland. Vector Borne Zoonotic Dis. 2017;17(7):510-3.
3.    Bente DA, Forrester NL, Watts DM, McAuley AJ, Whitehouse CA, Bray M. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome, and genetic diversity. Antiviral Res. 2013;100(1): Page no:159-89.
4.    Blair PW, Kuhn JH, Pecor DB, Apanaskevich DA, Kortepeter MG, Cardile AP, Polanco Ramos A, Keshtkar-Jahromi M. An emerging biothreat: Crimean-Congo hemorrhagic fever virus in southern and western Asia. Am J Trop Med Hyg. 2019;100(1):16-23. Burt FJ. Laboratory diagnosis of Crimean-Congo hemorrhagic fever virus infections. Future Virol. 2011; 6: Page no:831-41.
5.    Burt FJ, Swanepoel R, Braack LE. Enzyme-linked immunosorbent assays for the detection of antibodies to Crimean-Congo hemorrhagic fever virus in the sera of livestock and wild vertebrates. Epidemiol Infect. 1993;111(3):Page no: 547-57.
6.    Charrel RN, Attoui H, Butenko AM, Clegg JC, Deubel V, et al. Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect. 2004;10:Page no:1040-55.
7.    Christova I et.al, Country-wide seroprevalence studies on CrimeanCongo hemorrhagic fever and hantavirus infections in general population of Bulgaria. J Med Virol. 2017;89(10):1720-5.
8.    De Liberato C, Frontoso R, Magliano A, Montemaggiori A, Autorino GL, Sala M, Bosworth A, Scicluna MT. Monitoring for the possible introduction of Crimean-Congo hemorrhagic fever virus in Italy based on tick sampling on migratory birds and serological survey of sheep flocks. Prev Vet Med. 2018; 149:47-52.
9.    Khan A, et al. Viral Hemorrhagic Fevers. Seminars in Pediatric Infectious Diseases. Philadelphia: WB Saunders Co., 1997;8 (suppl 1):64-73.
10.    Papa A, Papadimitriou E, Christova I. The Bulgarian vaccine Crimean-Congo hemorrhagic fever virus strain. Scand J Infect Dis 2011;43: 225-9.
11.    Hawman DW, Feldmann H. Recent advances in understanding Crimean-Congo hemorrhagic fever virus. F1000Res. 2018;7: F1000 Faculty Rev-715.
12.    Crimean-Congo Hemorrhagic Fever - Iraq. World Health Organization. June 1, 2022. https://w ww.who.int/emergencies/disease-outbreak-news/item/2022-DON386 (Accessed on June 21, 20 22).

II.    BOOK REFERENCE:
13.    O. Ergonul and C. A. Whitehouse (eds.), Crimean-Congo Hemorrhagic Fever, 2007 Springer. Published by Berna Arda, Ahmet Aciduman, Page no: 13–22.
14.    Peters CJ. Viral Hemorrhagic Fevers. Viral Pathogenesis. New York: Lippincott-Raven     Publishers, 1997: Page no: 779-794.
15.    Watts DM et.al, Crimean-Congo hemorrhagic fever. In: Monath TP, editor. Volume 2. CRC Press; Boca Raton, FL, USA: 1988. Page no: 177–260.
16.    Transactions of The Royal Society of Tropical Medicine and Hygiene, Volume 109, 2015, Page no: 481–482
17.    Crimean-Congo Hemorrhagic Fever, Marmara University, School of Medicine, Altunizade, Turkey, first edition, Published by Springer Dordrecht, page no: 301-328.

Recomonded Articles:

Author(s): Sathyavathy. G

DOI: 10.52711/ijnmr.2023.14         Access: Open Access Read More

Author(s): Shanthi Ravichandran

DOI: 10.52711/ijnmr.2023.24         Access: Closed Access Read More

A and V Pub International Journal of Nursing and Medical Research (IJNMR) is an international, peer-reviewed journal devoted to nursing and medical sciences. IJNMR's aim is to promote excellence in nursing and health care through the publication of clinical information and original research....... Read more >>>

RNI:                      
DOI:  

Popular Articles


Recent Articles




Tags